|Maine Medicine Weekly Update
October 18, 2021
Draft Study Shows Moderna & Pfizer May Be Better Boost for J&J Recipients
A new National Institutes of Health (NIH) study suggested Moderna's or Pfizer's vaccine also work as a booster for J&J recipients and may benefit more from getting a Pfizer or Moderna vaccine as their booster instead of another J&J shot. The study is preliminary and hasn't been peer reviewed.
People who received an mRNA-based booster vaccination had a four-fold increase in their neutralization response more frequently than those who were boosted with J&J's adenovirus vaccine.
During the Friday meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), a top FDA official told the committee that the agency might consider allowing Johnson & Johnson recipients to receive a booster shot of the Moderna or Pfizer-BioNTech vaccines but gave no timetable for that decision.
Click here for NPR story on NIH study: NIH study of COVID-19 vaccine boosters suggests Moderna or Pfizer works best
Click here for a draft of the NIH study: Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report< Previous Article | Next Article >
[ return to top ]
ensure delivery of Maine Medicine Weekly Update,
please add 'firstname.lastname@example.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm
For more information or to contact us directly, please visit www.mainemed.com | ©